MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Functional connectome organization is altered in PD patients with mild cognitive impairment

    S. Galantucci, F. Agosta, I. Stankovic, S. Basaia, T. Stojkovic, E. Stefanova, E. Canu, A. Meani, V.S. Kostic, M. Filippi (Milan, Italy)

    Objective: The aim of the study was to investigate the functional brain connectome organization in patients with Parkinson's disease (PD) with mild cognitive impairment (MCI).…
  • 2016 International Congress

    The relationship among clinical features, DAT scintigraphy and MIBG cardiac scintigraphy in patients with Parkinson’s disease

    J. Ebina, T. Sekiguchi, M. Takahashi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: The aim of this study is to evaluate correlations among clinical features of Parkinson's disease (PD), odor stick identification test for Japanese (OSIT-J) score,…
  • 2016 International Congress

    In vivo MRI detection of Parkinson’s disease associated degeneration in the lateral ventral tier of substantia nigra pars compacta

    D.E. Huddleston, J. Langley, J. Sedlacik, K. Boelmans, S.A. Factor, X. Hu (Atlanta, GA, USA)

    Objective: To test a novel multimodal MRI approach for in vivo assessment of the subregion of substantia nigra pars compacta (SNpc) most vulnerable to Parkinson's…
  • 2016 International Congress

    Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease

    E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)

    Objective: We sought to determine: a) the ability of TYM to discriminate between PD patients with and without cognitive deficits b) equivalence between MoCA scores…
  • 2016 International Congress

    Cognitive and behavioral problems in children and adolescents with myoclonus dystonia

    M.A. Coenen, H. Eggink, H. van den Berg, J.M. Spikman, M.A. Tijssen (Groningen, Netherlands)

    Objective: To compare the neuropsychological and behavioral profile of A) children and adolescents with myoclonus dystonia (MD) to a healthy control group and B) MD…
  • 2016 International Congress

    Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

    R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)

    Objective: To study the value of various neuropsychological scales to determine the degree of cognitive dysfunction in patients with posttraumatic subcortical Parkinsonian dementia, during the…
  • 2016 International Congress

    Retrieval action verbs is impaired in Parkinson´s disease patients using a sentence completion task

    E. Herrera, R. Pérez, M. González-Nosti (Gijón, Spain)

    Objective: Our aim is to investigate if action verb retrieval is impaired, compared to sensorial verbs using a sentence completion task in non-demented Parkinson´s Disease…
  • 2016 International Congress

    Sensitivity of people with Parkinson’s to different intensities of emotions (SPiEs)

    J. Wincenciak, D.J. Burn, L.S. Delicato (Newcastle upon Tyne, United Kingdom)

    Objective: To characterise the ability of individuals with Parkinson's to discriminate the six universal facial expressions. Background: People with Parkinson's (PwP) tend to have difficulty…
  • 2016 International Congress

    The role of neuroinflammation in the development of Parkinson’s disease dementia

    A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

    Objective: To evaluate, at post-mortem, the pattern and characteristics of neuroinflammatory change in Parkinson's disease (PD) brain and to assess its relationship with aberrant alpha-synuclein,…
  • 2016 International Congress

    Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study

    S. Raha, L. Ebenezer (Bridgend, United Kingdom)

    Objective: Outcome of Rivastigmine treatment in Parkinson's disease Dementia (PDD). Effect of treatment on cognition and Neuropsychiatric symptoms. To compare clinical global impression of Clinicians…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley